Healthcare

By

Gary Berman

 | Jan 20, 2015 | 10:01 AM EST

I would look to buy the weakness inside the $102.30-$100.59 zone.

By

Timothy Collins

 | Jan 13, 2015 | 12:43 PM EST

Yesterday's action in the stock speaks volumes.

By

Kate Stalter

 | Jan 6, 2015 | 12:00 PM EST

They are prone to being whipsawed by news.

By

Chris Laudani

 | Dec 30, 2014 | 11:00 AM EST

Its hepatitis C drug will dominate the market.

By

Carolyn Boroden

 | Dec 29, 2014 | 9:00 AM EST

Here's how to trade some key price relationships.

By

David Katz

 | Dec 26, 2014 | 12:30 PM EST

Its hepatitis C drug is better; the stock trades at a discount.

By

Bret Jensen

 | Dec 26, 2014 | 11:18 AM EST

A high risk/high reward play.

By

Bret Jensen

 | Dec 23, 2014 | 12:00 PM EST

It has a great long-term future.

By

Gary Berman

 | Dec 22, 2014 | 10:15 AM EST

Has everyone buying the shares at runaway prices had enough yet?

By

Bret Jensen

 | Dec 19, 2014 | 12:00 PM EST

The company has what I look for in this speculative space.

Market is weathering election results from Greece quite well. After so many bailouts over...
No rest for the weary this week as the earnings season is in full bloom. The heaviest two...
The result of the Greek election looks likely to add to volatility in the euro's exchange ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.